Clinical Updates & Insights

Print

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed

Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.
Newsletter Sign Up

Manage Preferences

177 Clinical Updates found

Clinical Update

Immunotherapy and Efficacy of Chemo in Patients with Recurrent Ovarian Cancer

Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer.

  • Thursday, September 19, 2019

Clinical Update

Surgery for Advanced Ovarian Cancer Safe in Older Women

Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty.

  • Thursday, September 19, 2019

Clinical Update

New Imaging Method Can Diagnose and Direct Treatment of Rare Pediatric Retinoblastoma

Decreasing values for apparent diffusion coefficient (ADC) mapping derived from MRI may indicate the development of trilateral retinoblastoma in pediatric patients with bilateral retinoblastoma.

  • Monday, August 5, 2019

Clinical Update

Hepatic Arterial Infusion Converts “Unresectable” Colorectal Liver Mets

The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.

  • Friday, August 2, 2019

Clinical Update

New Molecular Signatures of High-Risk Neuroblastoma

High-risk neuroblastoma cells harbor distinguishing molecular signatures, according to recent research.

  • Friday, August 2, 2019

Clinical Update

Chemotherapy Reduces Seizures in Low-Grade Oligodendroglioma

Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.

  • Friday, June 28, 2019

Clinical Update

Minimizing Cardiotoxicities of Contemporary Breast Cancer Treatments

In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.

  • Friday, June 28, 2019

Clinical Update

Nasal Cavity Cancer: Radiation Is a Valid Option for Patients Refusing Surgery

Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Tackling Lymphedema: New Insights from MSK’s Dedicated Lab

New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Less Is Better: Promising Results for Reduced-Dose Radiation Therapy in High-Risk Pediatric Neuroblastoma

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.

  • Monday, May 13, 2019